This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Adams LV, Waddell RD, Fordham Von Reyn C. T-SPOT. TB Test® results in adults with Mycobacterium avium complex pulmonary disease. Scand J Infect Dis. 2008;40(3):196–203. doi:10.1080/00365540701642179 MedlineAdamsLVWaddellRDFordham Von ReynC.T-SPOT. TB Test® results in adults with Mycobacterium avium complex pulmonary diseaseScand J Infect Dis.200840(3):196–203. doi:10.1080/00365540701642179Medline18274952Open DOISearch in Google Scholar
Adzic-Vukicevic T, Barac A, Blanka-Protic A, Laban-Lazovic M, Lukovic B, Skodric-Trifunovic V, Rubino S. Clinical features of infection caused by non-tuberculous mycobacteria: 7 years’ experience. Infection. 2018;46(3):357–363. doi:10.1007/s15010-018-1128-2 MedlineAdzic-VukicevicTBaracABlanka-ProticALaban-LazovicMLukovicBSkodric-TrifunovicVRubinoS.Clinical features of infection caused by non-tuberculous mycobacteria: 7 years’ experienceInfection.201846(3):357–363. doi:10.1007/s15010-018-1128-2Medline29476412Open DOISearch in Google Scholar
Bakuła Z, Kościuch J, Safianowska A, Proboszcz M, Bielecki J, van Ingen J, Krenke R, Jagielski T. Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease. Respir Med. 2018;139:91–100. doi:10.1016/j.rmed.2018.05.007 MedlineBakułaZKościuchJSafianowskaAProboszczMBieleckiJvan IngenJKrenkeRJagielskiT.Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary diseaseRespir Med.201813991–100. doi:10.1016/j.rmed.2018.05.007Medline29858008Open DOISearch in Google Scholar
Borkowska D, Zwolska Z, Michałowska-Mitczuk D, Korzeniewska-Koseła M, Zabost A, Napiórkowska A, Kozińska M, Brzezińska S, Augustynowicz-Kopeć E. [Interferon-gamma assays T-SPOT.TB for the diagnosis of latent tuberculosis infection] (in Polish). Pneumonol Alergol Pol. 2011;79(4):264–271. MedlineBorkowskaDZwolskaZMichałowska-MitczukDKorzeniewska-KosełaMZabostANapiórkowskaAKozińskaMBrzezińskaSAugustynowicz-KopećE.[Interferon-gamma assays T-SPOT.TB for the diagnosis of latent tuberculosis infection] (in Polish)Pneumonol Alergol Pol.201179(4):264–271Medline10.5603/ARM.27644Search in Google Scholar
Borkowska DI, Napiórkowska AM, Brzezińska SA, Kozińska M, Zabost AT, Augustynowicz-Kopeć EM. From latent tuberculosis infection to tuberculosis. News in diagnostics (QuantiFERON-Plus). Pol J Microbiol. 2017;66(1):5–8. doi:10.5604/17331331.1234987 MedlineBorkowskaDINapiórkowskaAMBrzezińskaSAKozińskaMZabostATAugustynowicz-KopećEM.From latent tuberculosis infection to tuberculosis. News in diagnostics (QuantiFERON-Plus)Pol J Microbiol.201766(1):5–8. doi:10.5604/17331331.1234987Medline29359690Open DOISearch in Google Scholar
Demkow U. [Interferon gamma based tests as a new tool in diagnosis of latent tuberculosis] (in Polish). Pneumonol Alergol Pol. 2011;79(4):261–263. MedlineDemkowU.[Interferon gamma based tests as a new tool in diagnosis of latent tuberculosis] (in Polish)Pneumonol Alergol Pol.201179(4):261–263Medline10.5603/ARM.27643Search in Google Scholar
European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2016–2018. Stockholm (Sweden): European Centre for Disease Prevention and Control. 2018.European Centre for Disease Prevention and Control/WHO Regional Office for Europe.Tuberculosis surveillance and monitoring in Europe 2016–2018Stockholm (Sweden)European Centre for Disease Prevention and Control.2018Search in Google Scholar
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al.; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST MedlineGriffithDEAksamitTBrown-ElliottBACatanzaroADaleyCGordinFHollandSMHorsburghRHuittGIademarcoMFATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America.An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseasesAm J Respir Crit Care Med.2007175(4):367–416. doi:10.1164/rccm.200604-571STMedline17277290Open DOISearch in Google Scholar
Korzeniewska-Koseła M (editor). Gruźlica i choroby układu oddechowego w Polsce w 2017 roku. Warszawa (Poland): Instytut Gruźlicy i Chorób Płuc. 2018.Korzeniewska-KosełaM (editor). Gruźlica i choroby układu oddechowego w Polsce w 2017 rokuWarszawa (Poland)Instytut Gruźlicy i Chorób Płuc.2018Search in Google Scholar
Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, Leitch A, Loebinger MR, Milburn HJ, Nightingale M, et al. British Thoracic Society guidelines for the management of nontuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72 Suppl 2:ii1–ii64. doi:10.1136/thoraxjnl-2017-210927 MedlineHaworthCSBanksJCapstickTFisherAJGorsuchTLaurensonIFLeitchALoebingerMRMilburnHJNightingaleMBritish Thoracic Society guidelines for the management of nontuberculous mycobacterial pulmonary disease (NTM-PD)Thorax.201772 Suppl 2ii1–ii64. doi:10.1136/thoraxjnl-2017-210927Medline29054853Open DOISearch in Google Scholar
Hermansen TS, Thomsen VØ, Lillebaek T, Ravn P. Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark. PLoS One. 2014;9(4):e93986. doi:10.1371/journal.pone.0093986 MedlineHermansenTSThomsenVØLillebaekTRavnP.Non-tuberculous mycobacteria and the performance of interferon gamma release assays in DenmarkPLoS One.20149(4):e93986. doi:10.1371/journal.pone.0093986Medline397636724705675Open DOISearch in Google Scholar
Hoefsloot W, van Ingen J, Andrejak C, Ängeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, et al.; Nontuberculous Mycobacteria Network European Trials Group. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42(6):1604–1613. doi:10.1183/09031936.00149212 MedlineHoefslootWvan IngenJAndrejakCÄngebyKBauriaudRBemerPBeylisNBoereeMJCachoJChihotaVNontuberculous Mycobacteria Network European Trials Group.The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative studyEur Respir J.201342(6):1604–1613. doi:10.1183/09031936.00149212Medline23598956Open DOISearch in Google Scholar
Klatt M, Zabost A, Augustynowcz-Kopeć E. Diagnostyka mikrobiologiczna gruźlicy z zastosowaniem testów genetycznych XPERT MTB/RIF. Zakażenia. 2015;15(6):85–92.KlattMZabostAAugustynowcz-KopećE.Diagnostyka mikrobiologiczna gruźlicy z zastosowaniem testów genetycznych XPERT MTB/RIFZakażenia.201515(6):85–92Search in Google Scholar
Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Okimoto N, Matsushima T, Kageoka T, Oka M. Clinical evaluation of the Quanti FERON-TB Gold test in patients with non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis. 2009;13(11):1422–1426. MedlineKobashiYMouriKYagiSObaseYMiyashitaNOkimotoNMatsushimaTKageokaTOkaM.Clinical evaluation of the Quanti FERON-TB Gold test in patients with non-tuberculous mycobacterial diseaseInt J Tuberc Lung Dis.200913(11):1422–1426MedlineSearch in Google Scholar
Korzeniewska-Koseła M. Tuberculosis in Poland in 2015. Przegl Epidemiol. 2017;71(3):391–403. MedlineKorzeniewska-KosełaM.Tuberculosis in Poland in 2015Przegl Epidemiol.201771(3):391–403MedlineSearch in Google Scholar
Kuś J, Demkow U, Lewandowska K, Korzeniewska-Koseła M, Rabczenko D, Siemion-Szcześniak I, Białas-Chromiec B, Bychawska M, Sapigórski P, Maciejewski J. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10]. Pneumonol Alergol Pol. 2011;79(6):407–418. MedlineKuśJDemkowULewandowskaKKorzeniewska-KosełaMRabczenkoDSiemion-SzcześniakIBiałas-ChromiecBBychawskaMSapigórskiPMaciejewskiJ.[Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10]Pneumonol Alergol Pol.201179(6):407–418Medline10.5603/ARM.27624Search in Google Scholar
Mancuso JD, Mazurek GH, Tribble D, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW. Discordance among commercially available diagnostics for latent tuberculosis infection. Am J Respir Crit Care Med. 2012;185(4):427–434. doi:10.1164/rccm.201107-1244OC MedlineMancusoJDMazurekGHTribbleDOlsenCAronsonNEGeiterLGoodwinDKeepLW.Discordance among commercially available diagnostics for latent tuberculosis infectionAm J Respir Crit Care Med.2012185(4):427–434. doi:10.1164/rccm.201107-1244OCMedline329709822161162Open DOISearch in Google Scholar
Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182(7):970–976. doi:10.1164/rccm.201002-0310OC MedlinePrevotsDRShawPAStricklandDJacksonLARaebelMABloskyMAMontes de OcaRSheaYRSeitzAEHollandSMNontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systemsAm J Respir Crit Care Med.2010182(7):970–976. doi:10.1164/rccm.201002-0310OCMedline297086620538958Open DOISearch in Google Scholar
Ra SW, Lyu J, Choi C-M, Oh Y-M, Lee S-D, Kim WS, Kim DS, Shim TS. Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay. Int J Tuberc Lung Dis. 2011;15(5):635–640. doi:10.5588/ijtld.10.0485 MedlineRaSWLyuJChoiC-MOhY-MLeeS-DKimWSKimDSShimTS.Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assayInt J Tuberc Lung Dis.201115(5):635–640. doi:10.5588/ijtld.10.0485Medline21756514Open DOISearch in Google Scholar
Sato R, Nagai H, Matsui H, Kawabe Y, Takeda K, Kawashima M, Suzuki J, Ohshima N, Masuda K, Yamane A, et al. Interferongamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey. J Infect. 2016;72(6): 706–712. doi:10.1016/j.jinf.2016.03.011 MedlineSatoRNagaiHMatsuiHKawabeYTakedaKKawashimaMSuzukiJOhshimaNMasudaKYamaneAInterferongamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective surveyJ Infect.201672(6): 706–712. doi:10.1016/j.jinf.2016.03.011Medline27025204Open DOISearch in Google Scholar
Słupek A, Zwolska Z, Miller M, Rowińska-Zakrzewska E. [Pulmonary mycobacteriosis-diagnostic problem and prevalence in Poland (a retrospective study)]. (in Polish). Pneumonol Alergol Pol. 1997;65(5–6):326–332. MedlineSłupekAZwolskaZMillerMRowińska-ZakrzewskaE.[Pulmonary mycobacteriosis-diagnostic problem and prevalence in Poland (a retrospective study)]. (in Polish)Pneumonol Alergol Pol.199765(5–6):326–332MedlineSearch in Google Scholar
van der Werf MJ, Ködmön C, Katalinić-Janković V, Kummik T, Soini H, Richter E, Papaventsis D, Tortoli E, Perrin M, van Soolingen D, et al. Inventory study of non-tuberculous mycobacteria in the European Union. BMC Infect Dis. 2014;14(1):62–70. doi:10.1186/1471-2334-14-62 Medlinevan der WerfMJKödmönCKatalinić-JankovićVKummikTSoiniHRichterEPapaventsisDTortoliEPerrinMvan SoolingenDInventory study of non-tuberculous mycobacteria in the European UnionBMC Infect Dis.201414(1):62–70. doi:10.1186/1471-2334-14-62Medline392201224502462Open DOISearch in Google Scholar
Wang MS, Wang JL, Wang XF. The performance of interferongamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China. BMC Pulm Med. 2016;16(1):163. doi:10.1186/s12890-016-0320-3 MedlineWangMSWangJLWangXF.The performance of interferongamma release assay in nontuberculous mycobacterial diseases: a retrospective study in ChinaBMC Pulm Med.201616(1):163. doi:10.1186/s12890-016-0320-3Medline512422427887611Open DOISearch in Google Scholar
Wilińska E, Oniszh K, Augustynowicz-Kopeć E, Zabost A, Fijałkowska A, Kurzyna M, Wieteska M, Torbicki A, Kuś J, Szturmowicz M. Non-tuberculous mycobacterial lung disease (NTMLD) in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension. Pneumonol Alergol Pol. 2014;82(6):495–502. doi:10.5603/PiAP.2014.0066 MedlineWilińskaEOniszhKAugustynowicz-KopećEZabostAFijałkowskaAKurzynaMWieteskaMTorbickiAKuśJSzturmowiczM.Non-tuberculous mycobacterial lung disease (NTMLD) in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertensionPneumonol Alergol Pol.201482(6):495–502. doi:10.5603/PiAP.2014.0066Medline25339559Open DOISearch in Google Scholar
Zabost A, Augustynowicz-Kopeć E. Use of GenoType MTBDR plus assay for the detection of mycobacteria molecular rifampicin and isoniazid resistance. Post Nauk Med. 2015;4:249–254.ZabostAAugustynowicz-KopećE.Use of GenoType MTBDR plus assay for the detection of mycobacteria molecular rifampicin and isoniazid resistancePost Nauk Med.20154249–25410.5604/08606196.1151994Search in Google Scholar
